Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Complain of obstructive sleeping apnea and fatty liver is common in PCOS women so lifestyle changes are recommended
Forty obese PCOS men with obstructive sleeping apnea and compaint of fatty liver will participate in this trial . Group (study group) will contain twenty obese females with a complaint of PCOS and OSA and fatty liver. for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake, and daily walking for 30 minutes. Group (control group) will contain twenty obese females with a complaint of PCOS and OSA and fatty liver . for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake,
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| study | Experimental | this group will contain twenty obese females with a complaint of NAFLD, PCOS and OSA. for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake, and daily walking for 30 minutes |
|
| control group | Active Comparator | this group will contain twenty obese females with a complaint of NAFLD, PCOS and OSA. for eight weeks, these obese females will receive metformin tablet (thrice daily) and program of low diet intake |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| diet restriction and exercise | Behavioral | this group will contain twenty obese females with a complaint of NAFLD, PCOS and OSA. for eight weeks, these obese females will receive metformin tablet (thrice daily), program of low diet intake, and daily walking for 30 minutes |
| Measure | Description | Time Frame |
|---|---|---|
| aspartate transamianse | it will be assessed in serum after eight weeks |
| Measure | Description | Time Frame |
|---|---|---|
| alanine transaminase | it will be assessed in serum after eight weeks | |
| triglycerides | it will be assessed in serum after eight weeks | |
| neck circumference |
Not provided
Inclusion Criteria:
Exclusion Criteria:
self-identified national gender ID
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| faculty of physical therapy Cairo university | Recruiting | Dokki | Giza Governorate | Egypt |
Not provided
| ID | Term |
|---|---|
| D065626 | Non-alcoholic Fatty Liver Disease |
| ID | Term |
|---|---|
| D005234 | Fatty Liver |
| D008107 | Liver Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D015444 | Exercise |
| ID | Term |
|---|---|
| D009043 | Motor Activity |
| D009068 | Movement |
| D009142 | Musculoskeletal Physiological Phenomena |
| D055687 | Musculoskeletal and Neural Physiological Phenomena |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| diet restriction | Behavioral | this group will contain twenty obese females with a complaint of NAFLD, PCOS and OSA. for eight weeks, these obese females will receive metformin tablet (thrice daily) and program of low diet intake |
|
| it will be assessed after eight weeks |
| waist circumference | it will be assessed after eight weeks |
| body mass index | it will be assessed after eight weeks |
| testesterone | it will be assessed in serum after eight weeks |
| ratio of luteinizing hormone and follicle-stimulating hormone | it will be assessed after eight weeks |
| apnea hyopnea index | it will be assessed after eight weeks |
| Epworth sleeping scale | it will be assessed after eight weeks |
| Dehydroepiandrosterone | it will be assessed in serum after eight weeks |
| waist hip ratio | it will be assessed after eight weeks |
| faculty of physical therapy Cairo university | Recruiting | Dokki | Giza Governorate | Egypt |
|